Lexology March 7, 2024
Mintz

Click here to listen to the audio.

In this episode of Health Law Diagnosed, host Bridgette Keller is joined by Mintz Health Law attorneys Joanne Hawana and Benjamin Zegarelli to discuss the FDA’s long-awaited proposed rules that actively regulate laboratory developed tests (LDTs). LDTs have historically not been subject to significant regulatory oversight, and while the FDA aims to promptly release the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Provider, Regulations, Trends
Artificial heart saves 4th patient
PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain
FDA struggles to retain inspectors: GAO
How Do You Construct a Safe, Effective Algorithm?
FDA Aligns with Pharmacists in Ensuring Integrity of Drug Supply Chain | ASPL 2024

Share This Article